查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938696

2026年全球狂犬病診斷市場報告

Rabies Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，狂犬病診斷市場規模大幅擴大，預計將從2025年的17.8億美元成長到2026年的18.9億美元，複合年成長率為6.6%。過去幾年的成長可歸因於動物狂犬病的高發生率、人們對狂犬病預防意識的提高、獸醫診斷檢查室的增加、政府在狂犬病控制方面的舉措以及診斷劑和試劑盒的進步。

預計未來幾年狂犬病診斷市場規模將強勁成長，2030年將達到24.5億美元，複合年成長率（CAGR）為6.7%。預測期內的成長可歸因於人工智慧診斷工具的普及、對快速就地檢驗的增加、行動端疾病監測的擴展、分子和血清學技術的創新，以及公私合營在消除狂犬病方面的加強。預測期內的關鍵趨勢包括：快速照護現場狂犬病檢測、先進的分子診斷技術、人工智慧在狂犬病檢測中的應用、行動端狂犬病監測解決方案以及高靈敏度血清學檢測。

狂犬病日益普遍預計將推動狂犬病診斷市場的成長。狂犬病是一種可預防的病毒性疾病，最常見的傳播途徑是被患有狂犬病的動物咬傷。該病毒會攻擊哺乳動物的中樞神經系統，最終導致腦損傷和死亡。狂犬病診斷透過各種檢測和技術來檢測人類和動物體內是否存在狂犬病毒。此外，動物傳播感染疾病的日益增加也進一步推動了對狂犬病診斷的需求。例如，根據美國政府機構南達科他州衛生部（SD DOH）的數據，截至2024年4月，該州2023年共有20隻動物狂犬病檢測呈陽性，比2022年的9例增加了122%。在這些感染狂犬病的動物中，1隻為家畜（牛），其餘19隻為野生動物（包括18隻蝙蝠和1隻臭鼬）。因此，狂犬病日益普遍預計將推動狂犬病診斷市場的發展。

為了維持市場地位，狂犬病診斷市場的主要企業正在開發創新產品，例如狂犬病抗體檢測套組。狂犬病抗體檢測套組是一種診斷工具，用於檢測血液中的抗體，以評估免疫狀態和是否需要加強狂犬病疫苗接種。例如，2024年2月，美國診斷公司BioStone Animal Health推出了「AsurDx」試劑盒。本試劑盒採用快速、高靈敏度的ELISA方法檢測哺乳動物血清中狂犬病毒特異性抗體。它為評估已接種疫苗動物和高風險動物的狂犬病免疫力提供了一種經濟有效的解決方案。此試劑盒操作簡便，結果可靠，並保證符合0.5國際單位（IU）/毫升的狂犬病保護性免疫標準。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球狂犬病診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 快速現場狂犬病檢測
    • 先進的分子診斷技術
    • 將人工智慧應用於狂犬病檢測
    • 基於行動裝置的狂犬病監測解決方案
    • 高靈敏度血清學檢測

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷中心
  • 癌症安寧療護診所
  • 研究所
  • 獸醫診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球狂犬病診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球狂犬病診斷市場規模、比較及成長率分析
  • 全球狂犬病診斷市場表現：規模與成長，2020-2025年
  • 全球狂犬病診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過診斷方法
  • 螢光抗體檢測、免疫組織化學、擴增法、組織學、血清學
  • 透過技術
  • 酵素連結免疫吸附試驗（ELISA）或免疫組織化學、層析法技術、聚合酶鍊式反應（PCR）及其他技術
  • 最終用戶
  • 醫院、診斷中心、癌症安寧療護診所和其他最終用戶
  • 按類型細分：螢光
  • 直接螢光抗體檢測（DFA）
  • 按類型細分：免疫組織化學
  • 酵素免疫分析法（ELISA）、蛋白質印跡法
  • 按類型細分：擴增方法
  • 聚合酵素鏈鎖反應（PCR）、逆轉錄聚合酵素鏈鎖反應（RT-PCR）
  • 按類型細分：組織學檢查
  • 顯微鏡檢查、組織染色
  • 按類型細分：血清學檢測
  • 病毒中和試驗（VNT）、酵素免疫分析法（ELISA）

第10章 區域與國家分析

  • 全球狂犬病診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球狂犬病診斷市場：按國家、績效和預測分類，2020-2025 年、2025-2030 年預測、2035 年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 狂犬病診斷市場：競爭格局與市場佔有率，2024 年
  • 狂犬病診斷市場：公司估值矩陣
  • 狂犬病診斷市場：公司簡介
    • Bio-Rad Laboratories Inc.
    • The Merck Group
    • Aviva Systems Biology Corporation
    • Creative Diagnostics
    • Demeditec Diagnostics GmbH

第37章：其他領先和創新企業

  • Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN NV, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics SA, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年狂犬病診斷市場：提供新機會的國家
  • 2030年狂犬病診斷市場：新興細分市場機會
  • 狂犬病診斷市場2030：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: VH4MRDIA01_G26Q1

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

Tariffs have affected the rabies diagnostics market by increasing the cost of imported diagnostic kits, reagents, and molecular testing equipment, creating supply chain bottlenecks for PCR, ELISA, and fluorescent antibody test components. Regions like North America and Europe, which rely on imported precision diagnostic tools, are most impacted, particularly in hospital and diagnostic center segments. On the positive side, tariffs encourage local manufacturing and development of cost-effective diagnostic solutions, boosting regional production capabilities.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.78 billion in 2025 to $1.89 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to high prevalence of rabies in animals, increasing awareness of rabies prevention, growth of veterinary diagnostic laboratories, government initiatives for rabies control, advancement in diagnostic reagents and kits.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to adoption of ai-powered diagnostic tools, rising demand for rapid point-of-care tests, expansion of mobile-based disease surveillance, innovation in molecular and serology techniques, increasing public-private collaborations for rabies eradication. Major trends in the forecast period include rapid point-of-care rabies testing, advanced molecular diagnostic techniques, integration of ai in rabies detection, mobile-based rabies surveillance solutions, high-sensitivity serology testing.

The rising prevalence of rabies is expected to drive growth in the rabies diagnostics market. Rabies is a preventable viral disease most commonly transmitted through the bite of a rabid animal. The virus attacks the central nervous system of mammals, eventually causing brain damage and death. Rabies diagnostics are used to detect the presence of the rabies virus in humans and animals through various tests and techniques. Additionally, the increasing incidence of infectious diseases transmitted by animals has further boosted demand for rabies diagnostics. For example, in April 2024, according to the South Dakota Department of Health (SD DOH), a US-based government agency, South Dakota reported 20 animals testing positive for rabies in 2023, representing a 122% increase compared with 9 cases in 2022. Among the rabid animals, one was a domestic animal (a cow) and the remaining 19 were wild animals, including 18 bats and 1 skunk. Therefore, the growing prevalence of rabies is expected to propel the rabies diagnostics market.

Leading players in the rabies diagnostics market are developing innovative products, such as rabies antibody test kits, to maintain their market position. Rabies antibody test kits are diagnostic tools that detect antibodies in the blood to evaluate immunity or the need for additional rabies vaccination. For example, in February 2024, BioStone Animal Health, a US-based diagnostic company, launched AsurDx. The kit detects antibodies specific to the rabies virus in mammalian serum using a rapid and sensitive ELISA method. It provides a cost-effective solution for assessing rabies immunity in both vaccinated animals and those at risk. The kit is user-friendly, delivers reliable results, and ensures animals meet the standard of 0.5 international units (IU) per ml for protective immunity against rabies.

In November 2025, Zoetis Inc., a US-based provider of animal health medicines, vaccines, and veterinary diagnostic services, acquired Veterinary Pathology Group (VPG) for an undisclosed amount. Through this acquisition, Zoetis expanded its veterinary diagnostics capabilities in the United Kingdom and Ireland, enhancing its laboratory services, including rabies and other infectious disease testing, and improving its ability to deliver faster and more accurate diagnostic insights to veterinary professionals. Veterinary Pathology Group is a UK-based provider of multi-specialty veterinary diagnostic laboratory services, offering a wide range of tests to support clinical decision-making in animal health, including those relevant to rabies surveillance and diagnosis.

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation

North America was the largest region in the rabies diagnostics market in 2025. The regions covered in the rabies diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rabies Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
  • 2) By Technology: ELISA Or Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
  • 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
  • Subsegments:
  • 1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
  • 2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting
  • 3) By Amplification Methods: Polymerase Chain Reaction (PCR); Reverse Transcription PCR (RT-PCR)
  • 4) By Histologic Examination: Microscopic Examination; Tissue Staining Techniques
  • 5) By Serology Tests: Virus Neutralization Test (VNT); Enzyme-Linked Immunosorbent Assay (ELISA)
  • Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH; Abbexa Ltd.; Norgen Biotek Corp.; BioNote Inc.; Express Biotech International Inc.; MyBioSource Inc.; QIAGEN N.V.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Fluidigm Corp.; Bio-X Diagnostics S.A.; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Heska Corporation; IDEXX Laboratories Inc.; InBios International Inc.; KHB Shanghai Kehua Bio-Engineering Co. Ltd.; Meridian Bioscience Inc.; MP Biomedicals LLC; Neogen Corporation; Randox Laboratories Ltd.; SDIX LLC; Sigma-Aldrich Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Rabies Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Rabies Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Rabies Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Rabies Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rapid Point-Of-Care Rabies Testing
    • 4.2.2 Advanced Molecular Diagnostic Techniques
    • 4.2.3 Integration Of Ai In Rabies Detection
    • 4.2.4 Mobile-Based Rabies Surveillance Solutions
    • 4.2.5 High-Sensitivity Serology Testing

5. Rabies Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospital
  • 5.2 Diagnostic Centers
  • 5.3 Cancer Palliative Care Clinics
  • 5.4 Research Laboratories
  • 5.5 Veterinary Clinics

6. Rabies Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rabies Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Rabies Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Rabies Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Rabies Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Rabies Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rabies Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rabies Diagnostics Market Segmentation

  • 9.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
  • 9.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • ELISA Or Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
  • 9.3. Global Rabies Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Diagnostic Centers, Cancer Palliative Care Clinics, Other End-Users
  • 9.4. Global Rabies Diagnostics Market, Sub-Segmentation Of Fluorescent Antibody Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Fluorescent Antibody Test (DFA)
  • 9.5. Global Rabies Diagnostics Market, Sub-Segmentation Of Immunohistochemical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting
  • 9.6. Global Rabies Diagnostics Market, Sub-Segmentation Of Amplification Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
  • 9.7. Global Rabies Diagnostics Market, Sub-Segmentation Of Histologic Examination, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microscopic Examination, Tissue Staining Techniques
  • 9.8. Global Rabies Diagnostics Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Virus Neutralization Test (VNT), Enzyme-Linked Immunosorbent Assay (ELISA)

10. Rabies Diagnostics Market Regional And Country Analysis

  • 10.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rabies Diagnostics Market

  • 11.1. Asia-Pacific Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rabies Diagnostics Market

  • 12.1. China Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rabies Diagnostics Market

  • 13.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rabies Diagnostics Market

  • 14.1. Japan Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rabies Diagnostics Market

  • 15.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rabies Diagnostics Market

  • 16.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rabies Diagnostics Market

  • 17.1. South Korea Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rabies Diagnostics Market

  • 18.1. Taiwan Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rabies Diagnostics Market

  • 19.1. South East Asia Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rabies Diagnostics Market

  • 20.1. Western Europe Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rabies Diagnostics Market

  • 21.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rabies Diagnostics Market

  • 22.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rabies Diagnostics Market

  • 23.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rabies Diagnostics Market

  • 24.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rabies Diagnostics Market

  • 25.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rabies Diagnostics Market

  • 26.1. Eastern Europe Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rabies Diagnostics Market

  • 27.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rabies Diagnostics Market

  • 28.1. North America Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rabies Diagnostics Market

  • 29.1. USA Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rabies Diagnostics Market

  • 30.1. Canada Rabies Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rabies Diagnostics Market

  • 31.1. South America Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rabies Diagnostics Market

  • 32.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rabies Diagnostics Market

  • 33.1. Middle East Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rabies Diagnostics Market

  • 34.1. Africa Rabies Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Technology, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rabies Diagnostics Market Regulatory and Investment Landscape

36. Rabies Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Rabies Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Rabies Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Rabies Diagnostics Market Company Profiles
    • 36.3.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Rabies Diagnostics Market Other Major And Innovative Companies

  • Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc.

38. Global Rabies Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rabies Diagnostics Market

40. Rabies Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Rabies Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Rabies Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Rabies Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer